Search Results - Guoying Xu

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer

    A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer by Qingyuan Zhang, Bin Shao, Zhongsheng Tong, Quchang Ouyang, Yuting Wang, Guoying Xu, Shaorong Li, Huiping Li

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: